Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

22 December 2022: Clinical Research

Impact of the De Ritis Ratio on the Prognosis of Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

Kai Wang ABCE* , Zijun Chen ABE* , Deli Zeng BF , Maojuan Ran AEFG*

DOI: 10.12659/MSM.937737

Med Sci Monit 2022; 28:e937737

Table 1 Clinical data of the study population.

Overall populationLow De Ritis ratio (n=177)High De Ritis ratio (n=27)p value
Age (years), n (%)
22 (10.8)21 (11.9)1 (3.7)
 60–6958 (28.4)56 (31.6)2 (7.4)
 70–7971 (34.8)61 (34.5)10 (37.0)
 ≥8053 (26.0)39 (22.0)14 (51.9)
Men, n (%)142 (69.6)127 (71.8)15 (55.6)0.139
BMI (kg/m), n (%)0.002
17 (8.3)13 (7.3)4 (14.8)
 18.5–24.9119 (58.3)98 (55.4)21 (77.8)
 ≥25.068 (33.3)66 (37.3)2 (7.4)
Alb (g/dL) ≥4.0, n (%)115 (56.4)106 (59.9)9 (33.3)0.017
Hb (g/dL) (mean (SD))13.58 (2.01)13.80 (1.92)12.14 (2.02)
eGFR(mL/min/1.73 m) (mean [SD])61.32 (24.61)64.09 (23.42)43.15 (24.92)
CRP (mg/dL), n (%)0.964
 0.01–0.0334 (16.7)30 (16.9)4 (14.8)
 0.04–0.1164 (31.4)55 (31.1)9 (33.3)
 0.12–0.3355 (27.0)47 (26.6)8 (29.6)
 0.34–9.2051 (25.0)45 (25.4)6 (22.2)
AST (mean (SD))24.66 (10.93)24.58 (11.02)25.22 (10.52)0.776
ALT (mean (SD))20.90 (12.19)22.42 (12.24)10.93 (5.17)
LVEF (mean (SD))63.36 (9.88)63.51 (9.59)62.33 (11.81)0.564
OCI, n (%)35 (17.2)28 (15.8)7 (25.9)0.306
PAD, n (%)53 (26.0)45 (25.4)8 (29.6)0.819
Hypertension, n (%)151 (74.0)132 (74.6)19 (70.4)0.819
Diabetes mellitus, n (%)73 (35.8)65 (36.7)8 (29.6)0.617
Smoker, n (%)101 (49.5)94 (53.1)7 (25.9)0.015
Aspirin, n (%)202 (99.0)176 (99.4)26 (96.3)0.622
Thienopiridines, n (%)200 (98.0)174 (98.3)26 (96.3)1.000
Warfarin, n (%)5 (2.5)3 (1.7)2 (7.4)0.263
DOAC, n (%)21 (10.3)18 (10.2)3 (11.1)1.000
Statins, n (%)111 (54.4)101 (57.1)10 (37.0)0.082
ACEI/ARB, n (%)106 (52.0)90 (50.8)16 (59.3)0.543
βblocker, n (%)55 (27.0)46 (26.0)9 (33.3)0.57
MRA, n (%)11 (5.4)10 (5.6)1 (3.7)1.000
Bifurcation lesions, n (%)101 (49.5)85 (48.0)16 (59.3)0.378
Multivessel lesions, n (%)53 (26.0)47 (26.6)6 (22.2)0.808
LMT, n (%)13 (6.4)12 (6.8)1 (3.7)0.852
Calcification lesions, n (%)29 (14.2)23 (13.0)6 (22.2)0.326
CTO, n (%)12 (5.9)12 (6.8)0 (0.0)0.339
BMI – body mass index; Alb – serum albumin; Hb – hemoglobin; eGFR – estimated glomerular filtration rate; CRP – C-reactive protein; LVEF – left ventricular ejection fraction; OCI – old cerebral infarction; PAD – peripheral artery disease; DOAC – direct oral anticoagulant; MRA – mineralocorticoid receptor antagonists; LMT – left main trunk; CTO – chronic total occlusion.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750